Ben Clarke

First Name*

Last Name*

Email*

Phone*

Message*

I am authorized to claim this profile. I agree Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

First Name*

Last Name*

Email*

Phone*

Message*

Ben Clarke and Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

Contact Ben

Ben Clarke

Senior Scientist II

US Pharmacopeia

Dr. Ben Clarke coordinates collaborative for USP’s physical reference standards, for monoclonal antibodies, cell, and gene therapy. Before joining USP, Ben developed potency bioassays at GSK Vaccines for RSV and mRNA vaccines. His post-doctoral research at the National Institutes of Health involved the development of mouse models using the first generation of CRISPR/Cas9 genome editing technology. He received his Ph.D. in Cell Biology from Cornell University and his B.S. in Biochemistry from Pennsylvania State University.

Talks About
#assaydevelopment #cell

Preferred Locations
#NorthAmerica

Speaking Engagements

Cell Therapy CMC and Analytics

Paid

Cambridge Healthtech Institute’s Cell Therapy CMC and Analytics conference focuses on the characterization, control, and quality of cell-based therapies, supported by in-depth case studies and insight from leading industry and academic representatives. Topics include CMC regulatory requirements, product and process characterization, potency assays

14-15 August 2023

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Ben Clarke

Senior Scientist II

Speaking Engagements

Cell Therapy CMC and Analytics